Efficacy of Acarbose on Intestinal Microbiome and Incretins of Type 2 Diabetes
Status:
Unknown status
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
This study is aimed to investigate the effect of acarbose on intestinal microbiome and
incretins, therefore to explore the new pathways or new targets to treat type 2 diabetes.